RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Monash IVF Group - Stock

Monash IVF Group Stocks 2024

Monash IVF Group Stocks

392.43 M

Monash IVF Group Dividend yield

4.71 %

Ticker

MVF.AX

ISIN

AU000000MVF3

WKN

A116LZ

In 2024, Monash IVF Group had 392.43 M outstanding stocks, a 0% change from the 392.43 M stocks in the previous year.

The Monash IVF Group Stocks history

YEARNUMBER OF STOCKS (undefined AUD)
2027e392.43
2026e392.43
2025e392.43
2024e392.43
2023392.43
2022391.54
2021390.94
2020258.1
2019252.62
2018252.44
2017253.03
2016253.16
2015248.47
2014231.1
2013231.1
2012231.1
2011231.1
2010231.1

Monash IVF Group Aktienanalyse

What does Monash IVF Group do?

The Monash IVF Group Ltd is a company in Australia specializing in reproductive medicine. It was founded in 1970 by Professor Gab Kovacs, who is considered one of the pioneers in the field of in-vitro fertilization (IVF). The company's history began in a small laboratory in Melbourne, where the first successful IVF procedures were performed. Over time, Monash IVF grew and expanded its focus to include other reproductive treatments such as donor egg programs, sperm donation, and cryopreservation. Monash IVF Group Ltd has since become a leading provider in Australia, with 19 clinics throughout the country. The company is not only active in Australia but also operates clinics in Malaysia and Vietnam. The business model of Monash IVF Group Ltd is centered around helping couples and individuals fulfill their desire to have children. The company offers a wide range of treatments tailored to the individual needs and circumstances of each patient. Among the services offered are not only IVF, donor egg programs, and sperm donation but also other technologies such as intracytoplasmic sperm injection (ICSI) and preimplantation genetic diagnosis (PGD). Monash IVF Group Ltd sees itself as an all-rounder and therefore also offers psychological support and guidance during and after treatments. One of the company's specialties is its comprehensive research work. The Monash IVF Group has a specialized research department actively involved in researching new reproductive technologies. The company collaborates closely with universities and leading scientific institutes to gain the latest insights in this field and achieve the best possible outcomes for its patients. Monash IVF Group Ltd is divided into various divisions, each with different focuses and offerings. The main division is the Monash IVF Clinic, specializing in reproductive health and fertility. Here, all common IVF and fertility treatments are offered. Another division is Monash IVF Fertility Diagnostics, specializing in diagnostics and screening of fertility and reproductive problems. State-of-the-art diagnostic procedures for evaluating male and female fertility are used here. Monash IVF Genomics is another division offering genetic counseling, screening, and diagnostics. Here, couples can determine their genetic risk factors for fertility problems and receive support in making the best possible decisions regarding family planning. In addition to these divisions, Monash IVF Group Ltd also offers specialized services. For example, there is the Monash IVF Donor Program, specializing in the facilitation of anonymous and open donor programs. The Monash IVF DNA Matching can also assist in the search for genetic relatives by utilizing advanced DNA profiling. As a leading company in the field of fertility, Monash IVF Group Ltd offers a wide range of products and services to help couples and individuals fulfill their desire to have children. With a long history of innovation and research, as well as a variety of divisions and offerings, the company is an important provider of reproductive medicine in Australia and beyond. Monash IVF Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Monash IVF Group's Shares Outstanding

Monash IVF Group's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Monash IVF Group’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Monash IVF Group’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Monash IVF Group’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Monash IVF Group Stock

How many stocks are there of Monash IVF Group?

The current number of stocks of Monash IVF Group is 392.43 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Monash IVF Group are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Monash IVF Group evolved in recent years?

The number of shares of Monash IVF Group has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Monash IVF Group as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Monash IVF Group?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Monash IVF Group pay?

Over the past 12 months, Monash IVF Group paid a dividend of 0.06 AUD . This corresponds to a dividend yield of about 4.71 %. For the coming 12 months, Monash IVF Group is expected to pay a dividend of 0.06 AUD.

What is the dividend yield of Monash IVF Group?

The current dividend yield of Monash IVF Group is 4.71 %.

When does Monash IVF Group pay dividends?

Monash IVF Group pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Monash IVF Group?

Monash IVF Group paid dividends every year for the past 13 years.

What is the dividend of Monash IVF Group?

For the upcoming 12 months, dividends amounting to 0.06 AUD are expected. This corresponds to a dividend yield of 4.67 %.

In which sector is Monash IVF Group located?

Monash IVF Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Monash IVF Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Monash IVF Group from 4/5/2024 amounting to 0.036 AUD, you needed to have the stock in your portfolio before the ex-date on 3/7/2024.

When did Monash IVF Group pay the last dividend?

The last dividend was paid out on 4/5/2024.

What was the dividend of Monash IVF Group in the year 2023?

In the year 2023, Monash IVF Group distributed 0.063 AUD as dividends.

In which currency does Monash IVF Group pay out the dividend?

The dividends of Monash IVF Group are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Monash IVF Group

Our stock analysis for Monash IVF Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Monash IVF Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.